pre-clinical investigations

Show results for

Unknown (543)
Transcriptomics (36)
Genomics (28)
Proteomics (20)
Metabolomics (2)
Clinical (1)

Organisms

Homo sapiens (23)
Andropogon gerardi (14)
Bacteria (14)
Botrytis cinerea (14)
Canis lupus familiaris (14)
Clostridium perfringens (14)
Cnidaria (14)
Cricetulus griseus (14)
Eukaryota (14)
Fasciola (14)
Hepatitis B virus (14)
Human betaherpesvirus 5 (14)
Japanese encephalitis virus group (14)
Mesocricetus auratus (14)
Miscanthus x giganteus (14)
Mycobacterium tuberculosis (14)
Orthoflavivirus (14)
Panicum virgatum (14)
Platyhelminthes (14)
Pseudomonas aeruginosa AES-1R (14)
Mus musculus (9)
Rattus norvegicus (2)
Pimephales promelas (1)
Cryptopygus antarcticus (1)
Aedes aegypti (1)
Danio rerio (1)
Arabidopsis thaliana (1)
Chlorocebus aethiops (1)
Macaca fascicularis (1)
Macaca mulatta (1)

Organisms

Homo sapiens (7)
Mus musculus (4)
Mustela putorius furo (1)
Ovis aries (1)
Rattus norvegicus (1)

Repository

biostudies-arrayexpress (25)
ENA (25)
pride (14)
geo (12)
MassIVE (5)
EGA (2)
MetaboLights (2)
PanoramaPublic (1)

Tissue

Cell culture (5)
Blood plasma (2)
Blood serum (2)
Cardiac muscle tissue of ventricle (2)
Heart (2)
Cell suspension culture (1)
Cerebrospinal fluid (1)
Epithelial cell (1)
Fibroblast (1)
Liver (1)
Malignant cell (1)
Plant cell (1)
Regular ventricular cardiac myocyte (1)
Skin (1)
Skin fibroblast (1)
Thyroid gland (1)

Disease

Cardiovascular system disease (3)
Colorectal Neoplasms (1)
Charlevoix-Saguenay spastic ataxia (1)
Malignant neoplasm of ovary (1)

Technology Type

Mass Spectrometry (14)
Bottom-up proteomics (8)
Data-dependent acquisition (5)
Shotgun proteomics (5)
NMR spectroscopy assay (1)
Mass spectrometry (1)
Data-independent acquisition (1)

Instrument Platform

LTQ Orbitrap Elite (1)
Orbitrap Fusion (1)
Orbitrap Fusion Lumos (1)
Q Exactive (1)
TripleTOF 6600 (1)
Nuclear Magnetic Resonance (NMR) - - - Varian (1)
Nuclear Magnetic Resonance (NMR) - - - Bruker (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2022 (7)
2015 (6)
2025 (6)
2012 (5)
2026 (5)
2014 (4)
2010 (4)
2024 (4)
2016 (3)
2013 (3)
2021 (3)
2011 (2)
2018 (2)
2017 (2)
2009 (1)
2020 (1)
2019 (1)

CHEBI ID

CHEBI:16335 (2)
CHEBI:15971 (2)
CHEBI:17295 (2)
CHEBI:16919 (2)
CHEBI:49096 (1)
CHEBI:27247 (1)
CHEBI:16169 (1)
CHEBI:64703 (1)
CHEBI:84980 (1)
CHEBI:84979 (1)
CHEBI:186165 (1)
CHEBI:27524 (1)
CHEBI:82957 (1)
CHEBI:29959 (1)
CHEBI:17453 (1)
CHEBI:18401 (1)
CHEBI:48942 (1)
CHEBI:48944 (1)
CHEBI:15740 (1)
CHEBI:88493 (1)
CHEBI:170068 (1)
CHEBI:170157 (1)
CHEBI:170156 (1)
CHEBI:17282 (1)
CHEBI:606565 (1)
CHEBI:84981 (1)
CHEBI:13705 (1)
CHEBI:183136 (1)
CHEBI:156190 (1)
CHEBI:15595 (1)

Metabolite Name

Pi-methylhistidine (1)
Thiamine(1+) diphosphate (1)
9,10,18-trihydroxyoctadecanoic acid (1)
Ceramide phosphoethanolamine (d31:0) (1)
Ceramide phosphoethanolamine (t35:0) (1)
1-octadecyl-sn-glycero-3-phosphoinositol-3-phosphate (1)
Phosphatidylinositol (12:0) (1)
18-hydroxycorticosterone (1)
11-dehydrocorticosterone (1)
PA(20:2(11Z,14Z)/15:0) (1)
PA(15:0/20:2(11Z,14Z)) (1)
2-hydroxyoctanoic acid (1)
3-Hydroxyisovalerate (1)
Creatine phosphate (1)
Alpha-D-glucose (1)
D-ribose (1)
L-carnitine (1)
Tau-methylhistidine (1)
Trimethylamine (1)
3-hydroxybutyric acid (1)
L-isoleucine (1)
2-Oxoglutarate (1)
L-leucine (1)
L-histidine (1)
L-glutamine (1)
L-alanine (1)
9,10,13-Trihydroxystearic acid (1)
NAD+ (1)
O-Phosphocholine (1)
ATP (1)

First Public Date

2025 (8)
2026 (3)
2022 (3)
2021 (2)
2019 (2)
2014 (2)
2024 (1)
2020 (1)
2018 (1)
2017 (1)
2016 (1)

Study status

Completed (1)

Study type

Transcription profiling by array (21)
Comparative genomic hybridization by array (2)
RNA-seq of non coding RNA (2)
Interventional (1)

Release Date

2022 (80)
2021 (78)
2023 (69)
2025 (59)
2024 (57)
2020 (46)
2018 (29)
2019 (28)
2015 (22)
2017 (20)
2016 (17)
2014 (13)
2026 (11)
2013 (10)
2012 (10)
2010 (10)
2011 (4)
2008 (2)
2009 (1)
2007 (1)
2006 (1)

Lab affiliation

Executive Science Officer, BioFrontiers InstituteDistinguished ProfessorProfessor, Howard Hughes Medical Institute MOLECULAR CELLULAR AND DEVELOPMENTAL BIOLOGY CU DENVER SCHOOL OF MEDICINE (3)
IRCCS Istituto G Gaslini (2)
Bavarian Center for Biomolecular Mass Spectrometry Technische Universität München Gregor-Mendel-Straße 4 85354 Freising GERMANY (1)
Department of Pharmacy, University of Salerno (1)
First Affiliated Hospital, School of Medicine, Zhejiang University (1)
IRCCS G. Gaslini (1)
LIST-ERIN-BEAP Belvaux, LUXEMBOURG (1)
Max Planck Institute for Biochemistry Department of Proteomics and Signaltransduction Am Klopferspitz 18 D-82152 Martinsried (1)
Proteomics Team, Nestlé Institute of Health Sciences, Lausanne, Switzerland (1)
University of Piemonte Orientale (1)
University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (1)

Location

United States (1)

Previous page
1 / 63
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 63
Next page

Sort by:

Relevance

Page size

Pre-Clinical Investigations of the Pharmacodynamics of Immunogenic Smart Radiotherapy Biomaterials (iSRB).

Not available

S-EPMC10747552 | biostudies-literature

Efficient Generation of Bispecific Murine Antibodies for Pre-Clinical Investigations in Syngeneic Rodent Models.

Not available

S-EPMC5449386 | biostudies-literature

Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma.

Not available

S-EPMC4919237 | biostudies-literature

Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning.

Not available

S-EPMC8777683 | biostudies-literature

The optimal pre-post allocation for randomized clinical trials.

Not available

S-EPMC10045175 | biostudies-literature

A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology.

Not available

S-EPMC6509120 | biostudies-literature

Advancements in MDM2 inhibition: Clinical and pre-clinical investigations of combination therapeutic regimens.

Not available

S-EPMC10561124 | biostudies-literature

Wolbachia infection modifies the profile, shuttling and structure of microRNAs in a mosquito cell line

We characterized the miRNA composition of the nucleus and the cytoplasm of uninfected cells and compared it with the one of cells infected with the endosymbiotic bacterium Wolbachia strain wMelPop-CLA. We found an overall increase of small RNAs between 18 and 28 nucleotides in both cellular compartm...

ORGANISM(S): Aedes aegypti

2014-02-22 | E-GEOD-55210 | biostudies-arrayexpress

Real-world clinical validation of the Qatar pre-diabetes risk score: a cross-sectional study.

Not available

S-EPMC11812911 | biostudies-literature

Orthodontic camouflage versus orthodontic-orthognathic surgical treatment in borderline class III malocclusion: a systematic review.

Not available

S-EPMC9643255 | biostudies-literature

Previous page
1 / 63
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 63
Next page

Sort by:

Relevance

Page size

630 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Study status

Study type

Release Date

Lab affiliation

Location

OmicsDI is part of the ELIXIR infrastructure

Tweets